221 related articles for article (PubMed ID: 11836572)
1. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.
Hsieh TC; Wu JM
Int J Oncol; 2002 Mar; 20(3):583-8. PubMed ID: 11836572
[TBL] [Abstract][Full Text] [Related]
2. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of proliferation and expression of AR/PSA by herbal supplement Equiguard in LNCaP cells cultured in androgen-proficient FBS and androgen-deficient charcoal-stripped FBS is correlated with increased serine-15 phosphorylation of the tumor suppressor gene p53.
Lu X; Guo J; Hsieh TC; Wu JM
Anticancer Res; 2003; 23(3B):2489-98. PubMed ID: 12894532
[TBL] [Abstract][Full Text] [Related]
4. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.
Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991
[TBL] [Abstract][Full Text] [Related]
5. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.
Bonham M; Arnold H; Montgomery B; Nelson PS
Cancer Res; 2002 Jul; 62(14):3920-4. PubMed ID: 12124319
[TBL] [Abstract][Full Text] [Related]
6. Effects of PC-SPES on proliferation and expression of AR/PSA in androgen-responsive LNCaP cells are independent of estradiol.
Hsieh TC; Xiong W; Traganos F; Darzynkiewicz Z; Wu JM
Anticancer Res; 2002; 22(4):2051-60. PubMed ID: 12174883
[TBL] [Abstract][Full Text] [Related]
7. Prevention and management of prostate cancer using PC-SPES: a scientific perspective.
Hsieh TC; Lu X; Chea J; Wu JM
J Nutr; 2002 Nov; 132(11 Suppl):3513S-3517S. PubMed ID: 12421879
[TBL] [Abstract][Full Text] [Related]
8. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.
de la Taille A; Hayek OR; Burchardt M; Burchardt T; Katz AE
J Altern Complement Med; 2000 Oct; 6(5):449-51. PubMed ID: 11059508
[TBL] [Abstract][Full Text] [Related]
9. Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES.
Hsieh T; Chen SS; Wang X; Wu JM
Biochem Mol Biol Int; 1997 Jul; 42(3):535-44. PubMed ID: 9247711
[TBL] [Abstract][Full Text] [Related]
10. PC-SPES: a herbal therapy for the treatment of hormone refractory prostate cancer.
Meyer JP; Gillatt DA
Prostate Cancer Prostatic Dis; 2002; 5(1):13-5. PubMed ID: 15195124
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of herbal extracts used for treatment of prostatic disease on head and neck carcinoma cell lines and non-malignant primary mucosal cells.
Schmidt M; Polednik C; Roller J; Hagen R
Oncol Rep; 2013 Feb; 29(2):628-36. PubMed ID: 23165347
[TBL] [Abstract][Full Text] [Related]
12. UsToo PC-SPES surveys: review of studies and update of previous survey results.
Porterfield H
Mol Urol; 2000; 4(3):289-91;discussion 293. PubMed ID: 11062386
[TBL] [Abstract][Full Text] [Related]
13. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA].
Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562
[TBL] [Abstract][Full Text] [Related]
14. Contaminants of PC-SPES are not responsible for cytotoxicity in human small-cell lung carcinoma cells.
Sadava D; Winesburg J
Cancer Lett; 2005 Apr; 220(2):171-5. PubMed ID: 15766592
[TBL] [Abstract][Full Text] [Related]
15. Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells.
Thelen P; Peter T; Hünermund A; Kaulfuss S; Seidlová-Wuttke D; Wuttke W; Ringert RH; Seseke F
BJU Int; 2007 Jul; 100(1):199-203. PubMed ID: 17488304
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract.
Ye F; Jiang S; Volshonok H; Wu J; Zhang DY
Nutr Cancer; 2007; 57(1):100-10. PubMed ID: 17516867
[TBL] [Abstract][Full Text] [Related]
17. Ethanolic extracts of herbal supplement Equiguard suppress growth and control gene expression in CWR22Rv1 cells representing the transition of prostate cancer from androgen dependence to hormone refractory status.
Hsieh TC; Wu JM
Int J Oncol; 2008 Jan; 32(1):209-19. PubMed ID: 18097561
[TBL] [Abstract][Full Text] [Related]
18. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients.
de la Taille A; Hayek OR; Buttyan R; Bagiella E; Burchardt M; Katz AE
BJU Int; 1999 Nov; 84(7):845-50. PubMed ID: 10532984
[TBL] [Abstract][Full Text] [Related]
19. Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES.
Meade-Tollin LC; Wijeratne EM; Cooper D; Guild M; Jon E; Fritz A; Zhou GX; Whitesell L; Liang JY; Gunatilaka AA
J Nat Prod; 2004 Jan; 67(1):2-4. PubMed ID: 14738375
[TBL] [Abstract][Full Text] [Related]
20. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
